Experience by Phase

MedSource has participated in the early phases of development of novel therapeutics utilizing a variety of complex design clinical trials across the spectrum of the most challenging disease states. Over 75 percent of the studies have been either in Phase I or Phase II. The chart below illustrates the breadth of our experience in “healthy normal” studies as well as other early phase studies.

All Studies by Phase

Pie chart showing MedSource's experience in all phases of clinical trials, with the breadth of experience in early phase studies.